DK137047B - Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 6-(alfa-(amidino- eller imidoylamino-acylamino)-phenylacetamino)-penicillansyrer eller salte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 6-(alfa-(amidino- eller imidoylamino-acylamino)-phenylacetamino)-penicillansyrer eller salte deraf.

Info

Publication number
DK137047B
DK137047B DK422873AA DK422873A DK137047B DK 137047 B DK137047 B DK 137047B DK 422873A A DK422873A A DK 422873AA DK 422873 A DK422873 A DK 422873A DK 137047 B DK137047 B DK 137047B
Authority
DK
Denmark
Prior art keywords
imidoylamino
phenylacetamino
amidino
acylamino
racemic
Prior art date
Application number
DK422873AA
Other languages
Danish (da)
English (en)
Other versions
DK137047C (US06312121-20011106-C00033.png
Inventor
Ernest Seiichi Hamanaka
John Gerritt Stam
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK137047B publication Critical patent/DK137047B/da
Application granted granted Critical
Publication of DK137047C publication Critical patent/DK137047C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK422873AA 1972-08-02 1973-08-01 Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 6-(alfa-(amidino- eller imidoylamino-acylamino)-phenylacetamino)-penicillansyrer eller salte deraf. DK137047B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27706472A 1972-08-02 1972-08-02

Publications (2)

Publication Number Publication Date
DK137047B true DK137047B (da) 1978-01-09
DK137047C DK137047C (US06312121-20011106-C00033.png) 1978-08-07

Family

ID=23059254

Family Applications (1)

Application Number Title Priority Date Filing Date
DK422873AA DK137047B (da) 1972-08-02 1973-08-01 Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 6-(alfa-(amidino- eller imidoylamino-acylamino)-phenylacetamino)-penicillansyrer eller salte deraf.

Country Status (30)

Country Link
JP (1) JPS5318039B2 (US06312121-20011106-C00033.png)
AR (1) AR206879A1 (US06312121-20011106-C00033.png)
AT (1) AT327382B (US06312121-20011106-C00033.png)
AU (1) AU472676B2 (US06312121-20011106-C00033.png)
BE (1) BE803094A (US06312121-20011106-C00033.png)
BG (1) BG25798A3 (US06312121-20011106-C00033.png)
CA (1) CA1015355A (US06312121-20011106-C00033.png)
CH (1) CH574447A5 (US06312121-20011106-C00033.png)
CS (1) CS168459B2 (US06312121-20011106-C00033.png)
DD (1) DD106849A5 (US06312121-20011106-C00033.png)
DE (1) DE2338389A1 (US06312121-20011106-C00033.png)
DK (1) DK137047B (US06312121-20011106-C00033.png)
EG (1) EG10896A (US06312121-20011106-C00033.png)
ES (1) ES417461A1 (US06312121-20011106-C00033.png)
FI (1) FI56840C (US06312121-20011106-C00033.png)
FR (1) FR2194415B1 (US06312121-20011106-C00033.png)
GB (1) GB1418656A (US06312121-20011106-C00033.png)
HU (1) HU167653B (US06312121-20011106-C00033.png)
IE (1) IE37961B1 (US06312121-20011106-C00033.png)
IL (1) IL42820A (US06312121-20011106-C00033.png)
LU (1) LU68143A1 (US06312121-20011106-C00033.png)
NL (1) NL7310696A (US06312121-20011106-C00033.png)
NO (1) NO144831C (US06312121-20011106-C00033.png)
PH (1) PH12770A (US06312121-20011106-C00033.png)
PL (1) PL96500B1 (US06312121-20011106-C00033.png)
RO (2) RO63748A (US06312121-20011106-C00033.png)
SE (1) SE415977B (US06312121-20011106-C00033.png)
SU (2) SU576944A3 (US06312121-20011106-C00033.png)
YU (1) YU36966B (US06312121-20011106-C00033.png)
ZA (1) ZA735236B (US06312121-20011106-C00033.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024130A (en) * 1975-03-31 1977-05-17 Pfizer Inc. Process for the manufacture of alkali metal salts of 6-[2-phenyl-2-(imidoylaminoalkanoylamino)acetamido]penicillanic acids
US4073780A (en) * 1976-06-03 1978-02-14 Pfizer Inc. 4-Pyridylformimidoylglycyl-D-phenylglycine

Also Published As

Publication number Publication date
RO68719A2 (ro) 1980-08-15
BE803094A (fr) 1974-02-01
YU208673A (en) 1982-02-25
FI56840B (fi) 1979-12-31
FI56840C (fi) 1980-04-10
ZA735236B (en) 1974-07-31
DE2338389A1 (de) 1974-02-28
SE415977B (sv) 1980-11-17
AU5843373A (en) 1975-01-30
IL42820A (en) 1977-06-30
IE37961B1 (en) 1977-11-23
DD106849A5 (US06312121-20011106-C00033.png) 1974-07-05
IL42820A0 (en) 1973-10-25
FR2194415A1 (US06312121-20011106-C00033.png) 1974-03-01
IE37961L (en) 1974-02-02
ES417461A1 (es) 1976-03-01
NL7310696A (US06312121-20011106-C00033.png) 1974-02-05
PH12770A (en) 1979-08-17
DK137047C (US06312121-20011106-C00033.png) 1978-08-07
NO144831C (no) 1981-11-18
RO63748A (fr) 1979-01-15
PL96500B1 (pl) 1977-12-31
CA1015355A (en) 1977-08-09
SU576945A3 (ru) 1977-10-15
NO144831B (no) 1981-08-10
CH574447A5 (US06312121-20011106-C00033.png) 1976-04-15
JPS4945089A (US06312121-20011106-C00033.png) 1974-04-27
GB1418656A (en) 1975-12-24
AR206879A1 (es) 1976-08-31
YU36966B (en) 1984-08-31
SU576944A3 (ru) 1977-10-15
HU167653B (US06312121-20011106-C00033.png) 1975-11-28
JPS5318039B2 (US06312121-20011106-C00033.png) 1978-06-13
AU472676B2 (en) 1976-06-03
LU68143A1 (US06312121-20011106-C00033.png) 1974-02-11
FR2194415B1 (US06312121-20011106-C00033.png) 1976-12-31
ATA680773A (de) 1975-04-15
CS168459B2 (US06312121-20011106-C00033.png) 1976-06-29
AT327382B (de) 1976-01-26
BG25798A3 (en) 1978-12-12
EG10896A (en) 1976-07-31

Similar Documents

Publication Publication Date Title
DK128731B (da) Analogifremgangsmåde til fremstilling af α-phenoxysubstituerede aliphatiske carboxylsyrederivater eller salte deraf.
DK131728B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive alfa-aminocyclohexadienylalkylen-penicilliner eller -cephalosporiner eller salte deraf.
DK127000B (da) Analogifremgangsmåde til fremstilling af 6-[(-)-α-amino-p-hydroxyphenylacetamido]-penicillansyre eller salte deraf.
DK138602B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive penicilliner eller salte deraf.
DK124129B (da) Analogifremgangsmåde til fremstilling af heterocycliske carboxylsyrer eller salte deraf.
DK136527B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive p-alkoxyfenoxypropanolaminer eller syreadditionssalte deraf.
DK140281B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf.
DK126644B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive hydroxycrotonsyrer eller salte deraf med uorganiske eller organiske baser.
DK138020B (da) Analogifremgangsmåde til fremstilling af pyrazolodiazepinforbindelser eller salte deraf.
DK140545B (da) Analogifremgangsmåde til fremstilling af benzoylphenylsmørsyrederivater eller salte deraf.
DK137046B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 6-(alfa-(guanylureidoalkanoylamino)-phenylacetamino)penicillansyre-forbindelser eller salte deraf.
DK138599B (da) Analogifremgangsmåde til fremstilling af sulfamylantranilsyrer eller salte eller estre deraf.
DK120597B (da) Analogifremgangsmåde til frematilling af racemiske eller optisk aktive 10b-substituerede hexahydro-eller octahydrophenanthridinderivater eller salte deraf.
DK120709B (da) Analogifremgangsmåde til fremstilling af substituerede hydroxyfenyl-alkylaminer eller optisk aktive antipoder eller salte deraf.
DK123708B (da) Fremgangsmåde til fremstilling af polyencarboxylsyrer eller salte deraf.
DK129235B (da) Fremgangsmåde til fremstilling af racemiske eller optisk aktive quinolinderivater eller syreadditionssalte deraf.
DK138988B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive morphinanderivater.
DK137047B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 6-(alfa-(amidino- eller imidoylamino-acylamino)-phenylacetamino)-penicillansyrer eller salte deraf.
DK136823B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive derivater af imidazo(2,1-b)thiazol eller syreadditionssalte deraf.
DK138745B (da) Fremgangsmåde til fremstilling af cephalexin eller salte deraf.
DK138650B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive penicilliner.
DK140727B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive phosphiniminpenicilliner eller salte eller estere deraf.
DK138651B (da) Analogifremgangsmåde til fremstilling af penicilliner eller salte eller estere deraf.
DK122607B (da) Analogifremgangsmåde til fremstilling af heterocycliske carboxylsyrer eller salte deraf.
DK125467B (da) Analogifremgangsmåde til fremstilling af heterocycliske carboxylsyrer eller salte deraf.

Legal Events

Date Code Title Description
PBP Patent lapsed